Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

Aryl hydrocarbon receptor

  • Open Access
    Cross-talk of Aryl Hydrocarbon Receptor (AHR)- and Vitamin D Receptor (VDR)-signaling in Human Keratinocytes
    CHRISTOFOROS CHRISTOFI, LEANDROS LAMNIS, ALEXANDRA STARK, HEIKE PALM, KLAUS RÖMER, THOMAS VOGT and JÖRG REICHRATH
    Anticancer Research October 2022, 42 (10) 5049-5067; DOI: https://doi.org/10.21873/anticanres.16014
  • You have access
    The Dual Function of Aryl Hydrocarbon Receptor in Bladder Carcinogenesis
    JINGSONG YU, YAN LU, SATORU MUTO, HISAMITSU IDE and SHIGEO HORIE
    Anticancer Research March 2020, 40 (3) 1345-1357; DOI: https://doi.org/10.21873/anticanres.14076
  • You have access
    Aryl Hydrocarbon Receptor Antagonist StemRegenin 1 Promotes the Expansion of Human Promyelocytic Leukemia Cell Line, NB4
    RYOHEI KOIDE, KASEM KULKEAW, YUKA TANAKA, ANTHONY SWAIN, YOICHI NAKANISHI and DAISUKE SUGIYAMA
    Anticancer Research July 2016, 36 (7) 3635-3643;
  • You have access
    Prognostic Value of Nuclear Translocation of Aryl Hydrocarbon Receptor for Non-small Cell Lung Cancer
    JANG-MING SU, PINPIN LIN and HAN CHANG
    Anticancer Research September 2013, 33 (9) 3953-3961;
  • You have access
    Aryl Hydrocarbon Receptor and Lung Cancer
    JUNCHIEH J. TSAY, KAM-MENG TCHOU-WONG, ALISSA K. GREENBERG, HARVEY PASS and WILLIAM N. ROM
    Anticancer Research April 2013, 33 (4) 1247-1256;
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire